arrow
G

Georgios Giamas

first affiliated hospital of zhejiang chinese medical university
H指数:35
被引数:6,483

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Regulatory Element in the Intrinsically Disordered C-Terminal Region of LMTK3 Modulates Its Kinase Domain Interactions and Breast Cancer Phenotypes

LMTK3固有非结构化C末端区域中的调控元件调节其激酶域相互作用和乳腺癌表型

Cells
IF5.2
2026-08-270
OA
Orchestrating the metastatic symphony: the role of extracellular vesicles in the epithelial–mesenchymal transition and pulmonary niche formation of breast cancer

orchestrating the metastatic symphony: the role of extracellular vesicles in the epithelial–mesenchymal transition and pulmonary niche formation of breast cancer

2026-04-020
OAAI
INTEGRATED MULTI-OMICS AND MULTI-SPECTRAL PROFILING OF PLASMA EXTRACELLULAR VESICLES REVEALS HIGHLY ACCURATE LIQUID BIOPSY BIOMARKERS FOR GLIOMA DIAGNOSIS.

整合多组学和多重光谱分析血浆外泌体,揭示出高度准确的胶质瘤诊断液体活检生物标志物。

2025-10-010
OA
INVESTIGATING SHORT TERM (<6 MONTHS) SURVIVORS OF GLIOBLASTOMA - AN ANALYSIS OF THE HISTO-MOL GBM COLLABORATIVE DATABASE.

调查短期(<6个月)胶质母细胞瘤生存者——基于Histology-Molecular GBM Collaborative数据库的分析。

2025-10-010
OAAI
DEVELOPING AN EXTRACELLULAR VESICLE-BASED MULTI-OMIC LIQUID BIOPSY BIOMARKER SIGNATURE OF GLIOMA USING SAMPLES FROM THE GENOMICS ENGLAND BIOBANK

开发一种基于细胞外囊泡的多组学液体活检生物标志物签名,用于胶质瘤,使用来自基因组学英格兰生物样本库的样本

2025-09-020
OAAI
THE LANDSCAPE OF SECOND LINE (AND BEYOND) TREATMENTS FOR GLIOBLASTOMA (IDH WILDTYPE) IN THE UK IN 2021: AN UPDATE FROM THE HISTO-MOL GBM COLLABORATIVE

2021年英国IDH野生型胶质母细胞瘤的二线(及以上)治疗方案概况:来自Histo-Mol GBM Collaborative的更新

2025-09-020
OAAI
LMTK3 regulation of EV biogenesis and cargo sorting promotes tumour growth by reducing monocyte infiltration and driving pro-tumourigenic macrophage polarisation in breast cancer

LMTK3对EV生物发生和货物分选的调控通过减少单核细胞浸润并驱动促肿瘤性巨噬细胞极化,促进乳腺癌的生长。

2025-05-230
OA
GLIOBLASTOMA IN OLDER ADULTS, A NEED FOR BOLDER TREATMENT IN SELECTED PATIENTS?
2024-10-170
PRE
MOLECULAR GLIOBLASTOMAS - BETTER PROGNOSIS AFTER CORRECTING FOR TREATMENT DIFFERENCES
2024-10-170
PRE
GLIOBLASTOMA IN 2021, DEVELOPING A LARGE INDIVIDUAL PATIENT DATABASE TO INVESTIGATE OUTCOMES AND TREATMENT PATTERNS
2024-10-170
PRE